Anaphylaxis incidence with rocuronium, succinylcholine, and atracurium: how risk communication can influence behavior.
Service d'Anesthésie-Réanimation Chirurgicale, Groupe Hospitalier de Paris-Seine Saint Denis, AP-HP, Paris, France (P.D.). pascale.dewachter@yahoo.fr.
Pascale
P
Dewachter
Claudie
C
Mouton-Faivre
D000707:Anaphylaxis / Q000453:epidemiology* / Q000209:etiology*; D000732:Androstanols / Q000009:adverse effects*; D001279:Atracurium / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D019148:Neuromuscular Blockade / Q000009:adverse effects*; D003473:Neuromuscular Nondepolarizing Agents / Q000009:adverse effects*; D013390:Succinylcholine / Q000009:adverse effects*
D000732:Androstanols; D003473:Neuromuscular Nondepolarizing Agents; D001279:Atracurium; D013390:Succinylcholine